Services
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Non-Human Primate (NHP) Safety Pharmacology (CV, Resp, CNS) Study Service
Non-Human Primate (NHP) Safety Pharmacology: Accelerate Your Drug Discovery Process! Are you currently facing long drug development cycles, costly study failures, or challenges in obtaining high-fidelity safety data for regulatory submission? Our NHP Safety Pharmacology (CV, Resp, CNS) Study Service helps you de-risk your program, streamline the safety assessment process, and confidently advance your therapeutic candidates through advanced, integrated in vivo methodologies and expert analysis.
Introduction to NHP Safety Pharmacology
The journey of a new drug from discovery to market demands rigorous safety evaluation. The "Core Battery" of safety studies, focused on the cardiovascular, respiratory, and central nervous systems, is a mandatory step to predict potential adverse effects before clinical trials. At Creative Biolabs, our specialized service provides this critical data with unparalleled precision and reliability, empowering our clients to make informed, data-driven decisions.
What Our Service Is
Creative Biolabs' NHP Safety Pharmacology Service is a comprehensive in vivo solution designed to assess the potential for adverse cardiorespiratory and CNS effects of a new drug candidate. We provide an integrated, continuous data stream that reveals a drug's full physiological profile.
- Cardiovascular Safety Assessment. We evaluate a compound's impact on heart rate, blood pressure, and ECG parameters to identify potential for QT prolongation, arrhythmias, or other hemodynamic changes.
- Respiratory Function Analysis. Our services quantify a drug's effect on respiration, measuring tidal volume and respiratory rate to detect potential for depression or irritation, a crucial step for compounds targeting the CNS or respiratory system.
- Integrated CNS and Toxicology Studies. Our methods can be integrated into broader toxicology studies to provide a holistic view of the compound's effect on multiple organ systems.
Why Choose Us?
Creative Biolabs creates immense value for its clients by addressing key pain points in preclinical development. The traditional approach of conducting separate safety studies for each organ system often leads to longer timelines and increased costs. Our integrated approach provides a seamless solution, combining multiple assessments into a single study. This not only streamlines your workflow but also provides a richer, more comprehensive dataset. We use advanced telemetry and non-invasive technologies to deliver a complete picture of your compound's safety profile, helping you avoid costly and time-consuming retesting and regulatory delays.
Distributed under Unsplash License, from Unsplash.
Key Benefits of Our Service
Our service is built on a foundation of scientific excellence and a commitment to efficiency, providing a unique set of benefits for your drug development program.
- Highly Predictive NHP Resources: The close genetic and physiological similarities of NHPs to humans make them the most relevant model for predicting a drug's effects on the cardiorespiratory and nervous systems. This high degree of translational relevance is critical for meeting stringent regulatory requirements and building a robust safety case.
- Integrated Data Collection: We collect continuous, concurrent data on cardiovascular and respiratory parameters from conscious, freely-moving animals. This method eliminates the stress associated with restraint and provides a more accurate reflection of the drug's effects.
- Enhanced Reporting Depth: Our final reports include comprehensive statistical analysis and interpretation of the collected data, going beyond simple numbers to provide meaningful insights. This allows you to understand the full safety profile of your compound, with detailed analysis of dose-response relationships and time-dependent effects.
- Rapid Response & Flexibility: We understand the urgency of drug development. Our streamlined processes and dedicated team ensure a fast turnaround time from study initiation to final data delivery, enabling you to maintain momentum in your project. We also offer highly customizable study designs tailored to the unique characteristics of your compound and your specific regulatory needs.
How Creative Biolabs' Service Can Assist Your Project?
Our service provides a clear pathway to obtaining the essential safety data required to move your project forward with confidence. We offer a transparent, professional workflow grounded in scientific rigor and designed for your success.
01
Required Starting Materials
02
Study Design and Protocol Development
03
Animal Acclimation and Instrumentation
04
Dosing and Data Acquisition
05
Data Processing and Analysis
06
Final Report Generation
Key Deliverables
- Final Study Report: A comprehensive, professionally written report including a summary of methods, results, and expert conclusions, suitable for direct use in regulatory filings.
- Raw Data Files: All original data recordings in a standard format, allowing for independent analysis and review.
- Statistical Analysis Report: A detailed breakdown of all statistical findings, including dose-response and time-course analysis.
- Protocol and Amendments: A complete record of the study protocol and any subsequent amendments, ensuring full transparency and traceability.
Capabilities & Partnerships
Service-Specific Data
- Annual Sample Size: Over 50,000 samples analyzed per year.
- Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
- Study Pass Rate: 99%+ success rate in meeting study endpoints.
Our Valued Partners
Frequently Asked Questions
Q: Why do you recommend using NHPs for my safety pharmacology study?
A: Due to their genetic and physiological similarities to humans, NHPs are often the most predictive model for assessing potential drug effects on complex organ systems. This approach provides the highest confidence in your data and is frequently required by regulatory agencies for certain drug classes.
Q: Are there more cost-effective alternatives to using NHPs?
A: While there are in vitro assays and rodent models, they may not fully capture the complex integrated responses of the cardiovascular, respiratory, and nervous systems. Our integrated NHP service often eliminates the need for multiple, fragmented studies, providing a more comprehensive and ultimately more cost-effective solution in the long run by preventing costly delays.
Q: What is the typical turnaround time for this service?
A: The timeframe for each project is tailored to the study's specific requirements. However, our streamlined process and dedicated resources allow for a rapid turnaround, typically within 8-12 weeks. We can provide a more precise timeline once we have a clear understanding of your project's scope.
Q: How do you ensure the welfare and ethical treatment of the animals?
A: We are fully committed to the principles of the "three Rs" (replacement, reduction, and refinement). Our methods are designed to minimize the number of animals used and refine the procedures to reduce any potential stress. We adhere to the highest standards of animal welfare, as dictated by global regulatory guidelines.
Contact Us
Our NHP Safety Pharmacology (CV, Resp, CNS) Study Service provides a robust, integrated solution for de-risking your drug development program. By leveraging the predictive power of NHP models and advanced telemetry technology, we deliver the high-quality, comprehensive data required for successful regulatory submission. To learn more about how our services can assist your project, please contact us for a consultation.